Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| REPLIGEN CORPRGEN · Entity 486 | Director | March 01, 2022 | March 03, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
REPLIGEN CORP
Report date March 01, 2022 · Filed March 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,457 |
Reported balance
After 2022-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-03-01 · Exercise / conversion · Acquired 1,000 · Balance 3,457 F1: The total reported in Column 5 has been adjusted to correct an overstatement of total holdings by 9,880 shares, first reflected in a Form 4 filed on November 2, 2021. |
| Common StockSEC Table I · non-derivative | Direct | 2,457 |
Reported balance
After 2022-03-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2022-03-01 · Sale · Disposed 1,000 · Balance 2,457 F2: $198.48 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.19 to $198.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| Common StockSEC Table I · non-derivative | Direct | 1,457 |
Reported balance
After 2022-03-01 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2022-03-01 · Sale · Disposed 1,000 · Balance 1,457 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.76 · Expires 2030-11-11 | Direct | 0 |
Reported balance
After 2022-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-03-01 · Exercise / conversion · Acquired 1,000 · Balance 0 F3: This option is currently exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: The total reported in Column 5 has been adjusted to correct an overstatement of total holdings by 9,880 shares, first reflected in a Form 4 filed on November 2, 2021.
F2: $198.48 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.19 to $198.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3: This option is currently exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2022 Filed Mar 3, 2022 02:14 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $38.76 | $0.00 |
DisclosureSEC source: 0000899243-22-008827 · doc4.xml · derivative · entry 4 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2030-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 02:14 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 1,000 | $197.58 | $197,580.00 |
DisclosureSEC source: 0000899243-22-008827 · doc4.xml · nonDerivative · entry 3 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,457 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 02:14 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 1,000 | $198.48 | $198,480.00 |
DisclosureSEC source: 0000899243-22-008827 · doc4.xml · nonDerivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,457 F2 · price: $198.48 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.19 to $198.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 02:14 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 1,000 | $38.76 | $38,760.00 |
DisclosureSEC source: 0000899243-22-008827 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The total reported in Column 5 has been adjusted to correct an overstatement of total holdings by 9,880 shares, first reflected in a Form 4 filed on November 2, 2021. Read SEC document |
| November 04, 2021 Filed Nov 4, 2021 21:45 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 1,000 | $288.00 | $288,000.00 |
DisclosureSEC source: 0000899243-21-043040 · doc4.xml · nonDerivative · entry 3 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,337 Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 21:45 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,285 | $0.00 Strike: $128.18 | $0.00 |
DisclosureSEC source: 0000899243-21-043040 · doc4.xml · derivative · entry 4 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,285 shares Expires 2030-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is currently exercisable Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 21:45 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 1,285 | $302.00 | $388,070.00 |
DisclosureSEC source: 0000899243-21-043040 · doc4.xml · nonDerivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,337 F2 · price: $302.00 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.85 to $302.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 21:45 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 1,285 | $128.18 | $164,711.30 |
DisclosureSEC source: 0000899243-21-043040 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes three stock option exercises totaling 12,366 shares which were not previously included in the holder's beneficial ownership totals. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 23:33 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 780 | $250.50 | $195,390.00 |
DisclosureSEC source: 0000899243-21-031820 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 971 Read SEC document |
| May 13, 2021 Filed May 18, 2021 01:52 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 1,151 | $0.00 Strike: $169.65 | $0.00 |
DisclosureSEC source: 0000899243-21-019708 · doc4.xml · derivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,151 Underlying: Common Stock · 1,151 shares Expires 2031-05-13 F2 · derivative.exercise_date: Award vests in full on the earlier of May 13, 2022, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 13, 2021 Filed May 18, 2021 01:52 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019708 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,751 F1 · shares: Mr. Ryan was awarded 457 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 13, 2022, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:31 UTC | REPLIGEN CORP RGEN · Entity 486 | GiftCommon Stock | 170 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-012076 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,294 F1 · kind: The shares were disposed of in connection with a bona fide gift by the Reporting Person to a donor advised fund. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 02:22 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $26.12 | $0.00 |
DisclosureSEC source: 0000899243-21-010036 · doc4.xml · derivative · entry 3 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2026-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 02:22 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 1,000 | $205.00 | $205,000.00 |
DisclosureSEC source: 0000899243-21-010036 · doc4.xml · nonDerivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,464 Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 02:22 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 1,000 | $26.12 | $26,120.00 |
DisclosureSEC source: 0000899243-21-010036 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:46 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 934 | $0.00 Strike: $38.76 | $0.00 |
DisclosureSEC source: 0000899243-20-031001 · doc4.xml · derivative · entry 3 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 934 shares Expires 2027-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:46 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 934 | $187.73 | $175,339.82 |
DisclosureSEC source: 0000899243-20-031001 · doc4.xml · nonDerivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,464 F1 · price: $187.73 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.47 to $188.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:46 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 934 | $38.76 | $36,201.84 |
DisclosureSEC source: 0000899243-20-031001 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 23:50 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 2,109 | $0.00 Strike: $67.71 | $0.00 |
DisclosureSEC source: 0000899243-20-021251 · doc4.xml · derivative · entry 4 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,109 shares Expires 2029-05-15 F1 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 23:50 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 986 | $151.77 | $149,645.22 |
DisclosureSEC source: 0000899243-20-021251 · doc4.xml · nonDerivative · entry 3 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,464 Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 23:50 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 2,109 | $151.96 | $320,483.64 |
DisclosureSEC source: 0000899243-20-021251 · doc4.xml · nonDerivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,450 Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 23:50 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 2,109 | $67.71 | $142,800.39 |
DisclosureSEC source: 0000899243-20-021251 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2020 Filed May 20, 2020 00:45 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 1,285 | $0.00 Strike: $128.18 | $0.00 |
DisclosureSEC source: 0000899243-20-013635 · doc4.xml · derivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,285 Underlying: Common Stock · 1,285 shares Expires 2030-05-13 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 13, 2021. Read SEC document |
| May 13, 2020 Filed May 20, 2020 00:45 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 527 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-013635 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,450 F1 · shares: Mr. Ryan was awarded 527 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 13, 2021. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 21:10 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $42.07 | $0.00 |
DisclosureSEC source: 0000899243-20-008875 · doc4.xml · derivative · entry 5 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2028-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 21:10 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $38.76 | $0.00 |
DisclosureSEC source: 0000899243-20-008875 · doc4.xml · derivative · entry 4 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,934 Underlying: Common Stock · 500 shares Expires 2027-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 21:10 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 1,000 | $91.48 | $91,480.00 |
DisclosureSEC source: 0000899243-20-008875 · doc4.xml · nonDerivative · entry 3 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,923 F1 · price: $91.48 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.47 to $91.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 21:10 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 500 | $42.07 | $21,035.00 |
DisclosureSEC source: 0000899243-20-008875 · doc4.xml · nonDerivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 21:10 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 500 | $38.76 | $19,380.00 |
DisclosureSEC source: 0000899243-20-008875 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 22:53 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,804 | $0.00 Strike: $42.07 | $0.00 |
DisclosureSEC source: 0000899243-20-007242 · doc4.xml · derivative · entry 6 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 2,804 shares Expires 2028-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 22:53 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,992 | $0.00 Strike: $41.19 | $0.00 |
DisclosureSEC source: 0000899243-20-007242 · doc4.xml · derivative · entry 5 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,992 shares Expires 2025-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 22:53 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 4,796 | $88.82 | $425,980.72 |
DisclosureSEC source: 0000899243-20-007242 · doc4.xml · nonDerivative · entry 4 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,923 F2 · price: $88.82 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.51 to $89.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 22:53 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 2,804 | $42.07 | $117,964.28 |
DisclosureSEC source: 0000899243-20-007242 · doc4.xml · nonDerivative · entry 3 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 22:53 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 1,992 | $41.19 | $82,050.48 |
DisclosureSEC source: 0000899243-20-007242 · doc4.xml · nonDerivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 22:53 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 2,225 | $85.72 | $190,727.00 |
DisclosureSEC source: 0000899243-20-007242 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,923 F1 · price: $85.72 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.51 to $85.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:12 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 2,109 | $0.00 Strike: $67.71 | $0.00 |
DisclosureSEC source: 0000899243-19-013995 · doc4.xml · derivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,109 Underlying: Common Stock · 2,109 shares Expires 2029-05-15 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 15, 2020. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:12 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 923 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-013995 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,148 F1 · shares: Mr. Ryan was awarded 923 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 15, 2020. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| November 05, 2018 Filed Nov 6, 2018 23:29 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 1,763 | $65.75 | $115,920.42 |
DisclosureSEC source: 0000899243-18-028342 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,225 Read SEC document |
| August 22, 2018 Filed Aug 24, 2018 20:16 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 2,366 | $51.44 | $121,697.81 |
DisclosureSEC source: 0000899243-18-023221 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,988 F1 · price: $51.4361 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.39 to $51.501, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 06, 2018 Filed Jun 7, 2018 20:28 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 1,932 | $44.31 | $85,606.34 |
DisclosureSEC source: 0001140361-18-027688 · doc1.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,354 Read SEC document |
| May 16, 2018 Filed May 17, 2018 20:45 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 3,304 | $0.00 Strike: $42.07 | $0.00 |
DisclosureSEC source: 0001140361-18-024451 · doc1.xml · derivative · entry 3 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,304 Underlying: Common Stock · 3,304 shares Expires 2028-05-16 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 16, 2019. Read SEC document |
| May 16, 2018 Filed May 17, 2018 20:45 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 1,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-024451 · doc1.xml · nonDerivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,286 F1 · shares: Mr. Ryan was awarded 1,486 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 16, 2019. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:45 UTC | REPLIGEN CORP RGEN · Entity 486 | GiftCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-024451 · doc1.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 21:32 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,696 | $0.00 Strike: $18.12 | $0.00 |
DisclosureSEC source: 0001140361-18-013093 · doc1.xml · derivative · entry 5 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,696 shares Expires 2024-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 21:32 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001140361-18-013093 · doc1.xml · derivative · entry 4 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2021-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 21:32 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 4,696 | $36.16 | $169,791.86 |
DisclosureSEC source: 0001140361-18-013093 · doc1.xml · nonDerivative · entry 3 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,700 F1 · price: $36.1567 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.03 to $36.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 21:32 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 3,696 | $18.12 | $66,971.52 |
DisclosureSEC source: 0001140361-18-013093 · doc1.xml · nonDerivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 21:32 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 1,000 | $3.22 | $3,220.00 |
DisclosureSEC source: 0001140361-18-013093 · doc1.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2017 Filed May 22, 2017 21:02 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 2,434 | $0.00 Strike: $38.76 | $0.00 |
DisclosureSEC source: 0001140361-17-021760 · doc1.xml · derivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,434 Underlying: Common Stock · 2,434 shares Expires 2027-05-18 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 18, 2018. Read SEC document |
| May 18, 2017 Filed May 22, 2017 21:02 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 1,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021760 · doc1.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,700 F1 · shares: Mr. Ryan was awarded 1,206 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 18, 2018. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.